Diabetes Board decisions

The Veteran's diabetes mellitus Type II was not incurred in or aggravated by active duty, nor may it be presumed to have been incurred as a result of herbicide exposure. The claim is denied.

The Veteran's appeal is being remanded for additional development of his claims, including obtaining relevant treatment records and ensuring all applicable laws and regulations are considered.

The Veteran's claim for service connection for diabetes mellitus, type 2 and its associated peripheral neuropathy is being remanded due to the need for further development regarding exposure to Agent Orange in Vietnam and Thailand.

The Veteran requested withdrawal of the appeal for entitlement to service connection for hypertension, which was dismissed due to his request.

The Board found no evidence of service connection for the claimed conditions, including diabetes mellitus and peripheral vascular disease. The Veteran's conditions are not presumed to be related to herbicide exposure or any other service-connected condition.

The Board denied the Veteran's claims of service connection for seizures, an acquired psychiatric disability including schizophrenia, and diabetes mellitus. The decision is final as it was a denial on the merits.

The Board found that the Veteran's death was not caused by VA treatment, and thus DIC under 38 U.S.C.A. § 1151 is denied.

The Veteran's diabetes mellitus is currently rated at 20 percent, and the Board finds that a higher rating is not warranted based on the current evidence.

The Veteran's claims for service connection for prostate cancer and diabetes mellitus due to exposure to herbicides are being remanded for additional development, including obtaining outstanding VA treatment records and providing the Veteran with a VA examination.

The Board has determined that the Veteran's fatty liver, cirrhosis of the liver, and diabetes mellitus type II are related to his active duty service. The decision grants these claims.

The Veteran's service-connected disabilities, in conjunction with his education/training and work experience, render him unable to secure or follow a substantially gainful occupation.

The Veteran's appeals for a higher evaluation for diabetes and SMC based on need for aid and attendance or housebound status are being remanded to allow for additional development of the claims.

The Board denied the Veteran's claims for service connection for diabetes mellitus, hypertension, and muscle spasms of the lower legs. The reasons were that the Veteran did not serve in Vietnam during the Vietnam era, there was no evidence of herbicide exposure, and the conditions are not presumed to be related to service.

The Veteran's claims for service connection for diabetes mellitus, type II and a headache disorder (claimed as migraine headaches) are being remanded due to the need for additional development of his service treatment records and identification of all VA and non-VA health care providers who have treated him since his separation from service.

The Veteran's claim for service connection for hypertension is being remanded due to the need for clarification of medical opinions regarding the relationship between his hypertension and diabetes mellitus.

The Veteran's appeal is being remanded for further development to determine if he was exposed to herbicides during service and whether his claimed conditions are related to such exposure.

The Board has denied the Veteran's claims for service connection for various conditions, finding that new and material evidence was not submitted to reopen his claims. The appeals were based on direct service connection.

The Veteran's claims for service connection for a bilateral eye disorder and left foot pes planus were denied. The Board found no evidence of current disabilities or in-service incurrences that would support these claims.

The Board has remanded the case due to insufficient evidence regarding whether the Veteran's hypertension is related to his service-connected diabetes mellitus, type II.

The Veteran's type 2 diabetes mellitus is currently rated at 20 percent, but does not meet the criteria for a higher rating as it does not require regulation of activities in addition to diet and insulin.